Free Tdap vaccine now available nationwide for pregnant women in Malaysia

Although receiving the Tdap vaccine is not compulsory, the Health Ministry strongly encourages pregnant women to take part in this programme, aligning with the national life-course immunisation approach.

WT default author logo
Women's Tabloid News Desk

In a move aimed at strengthening protection for newborns, the Ministry of Health has introduced free Tdap (tetanus-diphtheria-pertussis) vaccinations for pregnant women between 28 and 32 weeks of gestation. This nationwide initiative is now in effect at all MOH primary healthcare centres that provide maternity services.

The announcement was made by Health Minister Datuk Seri Dr Dzulkefly Ahmad during the National Immunisation Day celebration. He explained that the immunisation effort is part of a broader strategy to safeguard infants, particularly from pertussis, commonly known as whooping cough, before they can complete their standard vaccination schedule.

“This vaccine aims to provide early protection to newborns who are highly vulnerable to complications from pertussis before completing their vaccination schedule,” said Dr Dzulkefly.

He further assured the public of the vaccine’s reliability, referencing global data on its use.
“International studies have also shown that this vaccine is safe and effective, without increasing risks to either mother or baby,” he said.

Although receiving the Tdap vaccine is not compulsory, the Health Ministry strongly encourages pregnant women to take part in this programme, aligning with the national life-course immunisation approach.

During the same event, Dr Dzulkefly shared an update on the Influenza Vaccination Programme for senior citizens, which began on February 18. It targets Malaysians aged 60 and above who live with chronic conditions. As of the latest count, 97,355 elderly individuals have received the influenza vaccine at public clinics across the country.

Emphasising the importance of public trust in medical programmes, Dr Dzulkefly addressed concerns about misinformation, noting that Malaysia’s national immunisation policy is regularly reviewed based on scientific research and international standards, with all vaccines undergoing rigorous efficacy and safety evaluations by the National Pharmaceutical Regulatory Agency (NPRA) and continuous monitoring by the Ministry of Health.

“There is a growing concern regarding the false dissemination of fake news and information, and this undermines public confidence. I understand that some parents are still unsure.

“I urge everyone to always refer to official sources because our decision today will affect the health of future generations,” he said.

With this new measure, the ministry reinforces its commitment to evidence-based policy, aiming to provide accessible and timely immunisation for key population groups.

Share:

Related Insights

WPS acquires Mavida Health to enter digital maternal mental care sector

Elation Health acquires Aster to expand agentic AI capabilities in United States primary care sector

Melinda French Gates pledges $215 million to tackle global gaps in women’s healthcare

Helaina and Nestlé partner to develop new bioactive proteins for infant nutrition

Connecticut Science Center secures long-term Aetna partnership for youth training

Aspira and Cleveland Clinic sign AI diagnostics research deal

GenoPalate and Mamaya Health form strategic partnership to offer integrated self-care solution for women

Zentalis Pharmaceuticals appoints Shannon Campbell and Sarah Kelly to key commercial leadership roles